Article
The role of molecular immunohematology in sickle cell disease.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis - 1 Feb 2011
Chou Stella T, Westhoff Connie M
Abstract excerpt
Red blood cell transfusion therapy is a key component in the treatment of patients with sickle cell disease (SCD). There is no universal standard of care for the appropriate selection of RBC products for patients with SCD. A number of programs extend antigen matching to E and C in the Rh system,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
